KCIC
PFE icon

Kuhn & Co Investment Counsel’s Pfizer PFE Stock Holding History

Kuhn & Co Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$427K Buy
15,215
+415
+3% +$11K 0.28% 92
2025
Q4 		$369K Buy
14,800
+330
+2% +$8.32K 0.25% 99
2025
Q3 		$369K Sell
14,470
-330
-2% -$8.14K 0.29% 93
2025
Q2 		$359K Hold
14,800
– – 0.27% 101
2025
Q1 		$375K Hold
14,800
– – 0.32% 95
2024
Q4 		$393K Buy
14,800
+240
+2% +$6.51K 0.33% 89
2024
Q3 		$421K Hold
14,560
– – 0.36% 88
2024
Q2 		$407K Buy
14,560
+90
+0.6% +$2.48K 0.37% 90
2024
Q1 		$402K Buy
+14,470
New +$402K 0.38% 86

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kuhn & Co Investment Counsel's PFE Position: Q1 2026 in Review

Kuhn & Co Investment Counsel increased its Pfizer (PFE) stake by 2.8% in Q1 2026, buying an estimated $11K and bringing the position to 15,215 shares worth $427K. The position accounts for 0.28% of the portfolio, ranked #92.

Kuhn & Co Investment Counsel first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Kuhn & Co Investment Counsel held 15,215 shares of Pfizer worth $427K as of Q1 2026.
  • Kuhn & Co Investment Counsel bought 415 Pfizer shares in Q1 2026, an estimated $11K.
  • Pfizer made up 0.28% of Kuhn & Co Investment Counsel's portfolio in Q1 2026, its #92 holding.
  • Kuhn & Co Investment Counsel first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.